UroLift System TOlerability and ReCovery When Administering Local Anesthesia

Completed · Not applicable

Conditions studied: Benign Prostatic Hyperplasia

In brief

The purpose of the study is to evaluate procedure tolerability and surgical recovery following the UroLift® system procedure when conducted with local anesthesia in subjects with symptomatic benign hyperplasia (BPH). Primary effectiveness will be achieved by looking at the Quality of Recovery Visual Analog Scale (QoR VAS) by the one month follow-up visit.

Key facts

Study ID

NCT01876706

Run by

NeoTract, Inc.

People needed

51

Starts

2013-04-01

Expected to finish

2018-09-04

Last updated by the study team

2019-03-20

Who can join

Age: 50 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Males age of 50 years or older diagnosed with symptomatic benign prostatic hyperplasia (BPH)

You may not qualify if…

• Size, volume,length of prostate

Where it is running

• Genesis Research LLC — San Diego, California, United States
• Advanced Urology Institute — Daytona Beach, Florida, United States
• Pinellas Urology — St. Petersburg, Florida, United States
• Chesapeake Urology — Baltimore, Maryland, United States
• Sheldon J. Freedman, M.D., Ltd. — Las Vegas, Nevada, United States
• Carolina Urologic Research Center — Myrtle Beach, South Carolina, United States
• Jean Brown Research — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.